Prostate Small Cell Carcinoma Not Yet Recruiting Phase 2 Trials for Abiraterone (DB05812)

IndicationStatusPhase
DBCOND0082092 (Prostate Small Cell Carcinoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03649841Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate CancerTreatment